MELI vs NKE: Which Is the Better Buy?

Side-by-side comparison of MercadoLibre, Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-09.
MercadoLibre, Inc. Β· Consumer Cyclical
$1,632.52
+45.0% upside to fair value
Grade B High Quality
VS
NIKE, Inc. Β· Consumer Cyclical
$42.62
+38.4% upside to fair value
Med Conviction Grade B+
QuantHub Verdict
MELI has more upside to fair value (+45.0%). NKE trades at a lower forward P/E (27.9x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MELI NKE
Current Price $1,632.52 $42.62
Fair Value Estimate $2,367.15 $58.98
Upside to Fair Value +45.0% +38.4%
Market Cap $82.8B $63.0B
Forward P/E 43.1x 27.9x
EV / EBITDA 22.5x 20.7x
Price / Sales 2.7x 1.4x
Price / FCF 7.2x 19.4x
Revenue Growth YoY +30.0% -9.8%
Gross Margin 45.5% 42.7%
Operating Margin 9.9% 8.0%
Return on Equity 29.6% 24.4%
Dividend Yield 0% 3.8%
FCF Yield 13.89% 5.2%
Analyst Consensus Strong Buy Buy
Investment Thesis
MELI β€” MercadoLibre, Inc.
MercadoLibre, Inc. operates a leading e-commerce and fintech platform in Latin America, combining a dominant commerce marketplace with a rapidly growing fintech segment. The company benefits from a durable competitive moat driven by network effects, strong brand recognition, and a comprehensive logistics infrastructure. Despite a recent earnings growth decline of 15.6% in the most recent quarter,…
NKE β€” NIKE, Inc.
Nike is the world's largest athletic footwear and apparel company with $46.3B in FY2025 revenue, operating across 190+ countries with the Nike, Jordan, and Converse brands. The stock trades near its 9-year low at $42.62 after an 11% single-day crash following a Q3 FY2026 earnings report that showed 35% net income decline and weak Q4 guidance calling for a further 2-4% revenue decline. FY2025 reve…
Accumulation Zones
Metric MELI NKE
Zone Low $1,775.36 $44.23
Zone High $2,012.08 $50.13
In Buy Zone? Yes Yes
← MELI Research    NKE Research β†’    All Research